Clicky

Revelation Biosciences, Inc.(REVB) News

Date Title
Jul 8 REVB Releases Positive Test Results—Potential Catalyst
Jun 24 Why Is Nano-Cap Revelation Biosciences Stock Skyrocketing On Monday?
Jun 24 Revelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker Activity
Feb 5 Revelation Biosciences Inc. Announces Closing of $6.2 Million Public Offering
Feb 1 Revelation Biosciences Inc. Announces Pricing of $6.2 Million Public Offering
Jan 30 Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)
Oct 4 Revelation Biosciences, Inc. to Present at the 2023 ROTH Healthcare Opportunities Conference
Oct 2 Revelation Biosciences Inc. Announces Appointment of Lakhmir Chawla, M.D. to Board of Directors